CD248, targeted by veratramine and neobavaisoflavone, mediates pathological changes of renal tubular epithelial cells induced by high glucose
Mei Lin, Nan Hu, Zhen Wang, Ping Li, Dan Song, Xinzhou Zhang · 2025
Read CD248, targeted by veratramine and neobavaisoflavone, mediates pathological changes of renal tubular epithelial cells induced by high glucose by Mei Lin, Nan Hu, Zhen Wang, Ping Li, Dan Song, Xinzhou Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12781830.txt.
Description
Mei Lin and five colleagues finger a cell-surface protein as a driver of diabetic kidney damage and find two plant compounds that target it, in a study published in two thousand twenty-five. In diabetic nephropathy, kidney tubule cells transform destructively under high glucose. The protein CD248 was suspected from fibrosis research.
Virtual screening and docking nominated veratramine and a soy isoflavone as CD248 binders, confirmed by thermal shift assays. Human tubule cells bathed in high glucose modeled the disease, and diabetic mice provided the animal test. Silencing the protein and dosing the compounds were compared. If a natural compound can block the transition driving kidney scarring, diabetic nephropathy gains a drug lead from an unexpected shelf.
Catalog record
| CREATOR | Mei Lin, Nan Hu, Zhen Wang, Ping Li, Dan Song, Xinzhou Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |